RNA, U6 small nuclear 623, pseudogene (RNU6-623P)

RNU6-623P (RNA, U6 small nuclear 623, pseudogene) is classified as a pseudogene of the human U6 small nuclear RNA (snRNA) family[1]. Pseudogenes are genomic DNA fragments derived from ancestral functional genes that have lost their ability to encode functional RNA or protein products, though some may retain partial sequence similarity to their parent genes and may be transcribed[3]. RNU6-623P shares sequence homology with U6 snRNA and retains authentic U6 5’ and 3’ ends, suggesting it is an unprocessed pseudogene fragment[1]. Pseudogenes may occasionally regulate gene expression through RNA-based mechanisms, but there is no evidence that RNU6-623P is transcribed, has biological function, or is relevant as a disease biomarker or therapeutic target[1][2][3]. It should not be considered a target for drug development or biological research in the context of receptors, enzymes, channels, or classical druggable targets. Because it is a pseudogene (with no documented transcription, no protein product, and no established biological or disease associations), RNU6-623P is not a receptor, enzyme, transporter, or therapeutic target[1][3]. Its inclusion as a target molecule is therefore incorrect for purposes of biological validation, disease linkage, or drug targeting. If you need information about a functional U6 small nuclear RNA (snRNA), refer instead to U6 snRNA, which is a component of the spliceosome, critical for mRNA splicing in eukaryotes.

Other names

RNU6-623PU6 snRNA pseudogene 623

none